The company’s leadership discussed its recent investments in robotic surgery technology during Johnson & Johnson’s 2019 fourth-quarter earnings call on 22 January. The company will provide more information on its robotic surgery platforms at its investors meeting in May in New York.
Johnson & Johnson CEO Alex Gorsky emphasized his company’s commitment to developing technology for robotic-assisted surgery during the company’s 2019 fourth-quarter earnings call on 22 January.
J&J is late to the robotic-assisted surgery market, but the health-care giant has made a series of acquisitions in robotic-assisted surgery technologies – which it calls digital surgery – and robotic-assisted surgery is a major reason why its research and development budget grew 5.4% to $11.35bn in 2019
Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.
As it celebrates 75 years shaping the medtech industry, Medtronic invited Medtech Insight to its Minneapolis headquarters to get a closer look at the company’s past, what it’s working on now, and what’s on the horizon.
DUALTO’s double-module option provides enhanced flexibility while cutting down on equipment clutter. Compared to traditional setups, the system reduces OR footprint by 46%, helping staff reclaim space and optimize surgical workflows.
